Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
240.50    5.00 (2.12%)
Bid:
239.00
Ask:
240.00
Spread: 1.00 (0.418%)
Market Cap: £1.43b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Board Changes

28 May 2021 10:15

RNS Number : 1920A
Mitchells & Butlers PLC
28 May 2021
 

28 May 2021

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

 

Board Changes

 

 

Mitchells & Butlers plc announces the following changes to its Board.

 

Ron Robson, who joined the Board in 2010, and is a nominated representative of the Group's largest shareholder, the Odyzean Group, Imelda Walsh, Chair of the Remuneration Committee, and Colin Rutherford, Chair of the Audit Committee, who both joined the Board in 2013, will all retire from the Board at the end of July 2021.

 

Following these changes , the Board of M&B will be comprised of the non-executive chairman, Bob Ivell, two executive directors (Phil Urban, CEO and Tim Jones, CFO), three independent non-executive directors (Susan Murray, who will remain as senior independent director, Jane Moriarty, who will assume the role of chair of the Audit Committee, and Dave Coplin, who will continue in his role as non-executive director nominated for representation of the "workforce voice") and three non-executive directors representing the interests of the Odyzean Group (Eddie Irwin, Josh Levy and Keith Browne).

 

An announcement in relation to the chairmanship of the Remuneration Committee is expected to be made in the next few months.

 

The office of Deputy Chairman currently held by Mr Robson will not be continued.

 

Commenting on these changes, chairman Bob Ivell said:

 

Ron, Imelda and Colin have provided excellent service to M&B throughout their time on the Board, helping to achieve a significant period of stability for the Company whilst assisting our governance and oversight arrangements.

 

We are extremely grateful to all three of these highly regarded non-executive directors for the support, guidance and enthusiasm which they have brought to the Board and everyone at M&B wishes them every success for the future.

 

In its prospectus issued on 22 February 2021, the Company confirmed that the Odyzean Group, which comprises shareholders with a majority of the shares in the Company, would review the composition of the Board to streamline its decision making and reduce the number of non-executive directors. By making these changes now, the smaller, more agile Board is in line with the Company's stated intentions at the time of the equity raise and it can now focus on supporting and challenging management over the coming months, as the business first recovers and then moves forward again.

 

We hope to make a further announcement in the near future in relation to the position of chair of the Remuneration Committee which should conclude this process.

 

For further information, please contact:

 

Greg McMahon

Company Secretary & General Counsel

0121 498 6514

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKFBPFBKKAPB
Date   Source Headline
12th Mar 20183:40 pmRNSDirector/PDMR Shareholding
12th Mar 201812:30 pmRNSChange to Director's Details - Stewart Gilliland
28th Feb 201811:15 amRNSTotal Voting Rights
12th Feb 20183:15 pmRNSDirector/PDMR Shareholding
8th Feb 20183:31 pmRNSDirector/PDMR Shareholding
8th Feb 201810:45 amRNSHolding(s) in Company
8th Feb 201810:26 amRNSDirector/PDMR Shareholding
7th Feb 20183:36 pmRNSDirector/PDMR Shareholding
6th Feb 20189:45 amRNSTotal Voting Rights
31st Jan 201812:30 pmRNSTotal Voting Rights
29th Jan 20183:30 pmRNSAdditional Listing
24th Jan 201810:30 amRNSResult of Annual General Meeting
15th Jan 20183:54 pmRNSDirector/PDMR Shareholding
12th Jan 20187:00 amRNSFirst Quarter Trading Update
10th Jan 20182:00 pmRNSNotice of first quarter trading update
2nd Jan 201811:50 amRNSTotal Voting Rights
21st Dec 201712:07 pmRNSAnnouncement of Scrip Reference Share Price
18th Dec 201711:19 amRNSDirector/PDMR Shareholding
14th Dec 201712:00 pmRNSAnnual Report 2017
11th Dec 201712:08 pmRNSDirector/PDMR Shareholding
30th Nov 20173:57 pmRNSTotal Voting Rights
30th Nov 201711:00 amRNSShort-Term Deferred Incentive Plan
23rd Nov 20177:00 amRNSFULL YEAR RESULTS
20th Nov 20172:45 pmRNSDirector/PDMR Shareholding
15th Nov 20172:00 pmRNSNotice of Final Results
31st Oct 20172:30 pmRNSTotal Voting Rights
23rd Oct 20173:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20173:00 pmRNSBlock listing Interim Review
29th Sep 201710:30 amRNSTotal Voting Rights
25th Sep 20173:00 pmRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSPre-Close Trading Update
15th Sep 201711:00 amRNSNotice of Pre-Close Trading Statement
31st Aug 20172:27 pmRNSTotal Voting Rights
29th Aug 201711:15 amRNSDirector/PDMR Shareholding
17th Aug 201712:30 pmRNSHolding(s) in Company
17th Aug 201712:00 pmRNSHolding(s) in Company
31st Jul 201712:19 pmRNSDirector/PDMR Shareholding
31st Jul 201710:30 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSThird Quarter Trading Update
24th Jul 201711:00 amRNSNotice of Third Quarter Trading Update
12th Jul 20172:00 pmRNSAdditional Listing
7th Jul 20172:30 pmRNSDirector/PDMR Shareholding
4th Jul 20174:00 pmRNSDirector/PDMR Shareholding
3rd Jul 20173:29 pmRNSDirector/PDMR Shareholding
30th Jun 20172:30 pmRNSTotal Voting Rights
27th Jun 20172:00 pmRNSAdditional Listing
27th Jun 201710:30 amRNSDirector/PDMR Shareholding
22nd Jun 20173:59 pmRNSHolding(s) in Company
22nd Jun 20172:45 pmRNSDirector/PDMR Shareholding
22nd Jun 20172:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.